Contact the Editorial Desk

Editorial correspondence

This desk welcomes notes on the record itself: a citation quoted imprecisely, a newly published study on GHK-Cu, GLOW's individual ingredients, or Melanotan II that belongs on the references page, or a regulatory update that shifts an approval or safety status. Given that one of the three compounds covered here — Melanotan II — has a serious documented safety record, corrections that make that record more accurate or more current are treated with particular care.

The most useful notes name three things: which page, the exact passage in question, and a supporting source — a DOI or PubMed identifier wherever possible. That shape lets a proposed correction be checked against its source before anything on the site changes.

Editorial mailbox: editors@agedefyingpeptides.com

Beyond what this desk can answer

So no message goes unanswered for the wrong reason, a few kinds of requests fall outside what this site does. Because Age Defying Peptides reports the literature rather than practicing medicine or selling anything, it cannot:

• Advise on or endorse human use of GHK-Cu, GLOW, or Melanotan II.
• Name a dose, schedule, or route for any individual.
• Judge whether a finding from a cited study applies to a specific person's situation.
• Help source, verify, or recommend a supplier of any peptide covered here.
• Provide guidance for anyone subject to anti-doping testing, since one compound discussed on this site involves an ingredient on the WADA Prohibited List.

Anyone with a medical question, especially concerning a new or changing mole or any symptom after using a peptide, should see a licensed clinician directly rather than waiting on a reply here. Replies to general correspondence are not guaranteed and can take time.